Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

被引:0
|
作者
Hamadeh, Issam [1 ]
Shekarkhand, Tala [1 ]
Rueda, Colin [1 ]
Firestone, Ross [1 ]
Wang, Alice [1 ]
Korde, Neha [1 ]
Hultcrantz, Malin [1 ]
Lesokhin, Alexander [1 ]
Mailankody, Sham [1 ]
Hassoun, Hani [1 ]
Shah, Urvi [1 ]
Maclachlan, Kylee [1 ]
Patel, Dhwani [1 ]
Shah, Gunjan [1 ]
Scordo, Michael [1 ]
Lahoud, Oscar [1 ]
Chung, David [1 ]
Landau, Heather [1 ]
Giralt, Sergio [1 ]
Usmani, Saad [1 ]
Tan, Carlyn Rose [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-013
引用
收藏
页码:S40 / S40
页数:1
相关论文
共 50 条
  • [1] Patterns of Cytokine Release Syndrome with Teclistamab in Relapsed/Refractory Multiple Myeloma with or without Prior T-Cell Redirection Therapy
    Hamadeh, S.
    Shekarkhand, Tala
    Rueda, Colin
    Firestone, Ross
    Wang, Alice
    Korde, Neha
    Hultcrantz, Malin
    Lesokhin, Alexander
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi A.
    Maclachlan, Kylee H.
    Patel, Dhwani
    Shah, Gunjan L.
    Scordo, Michael
    Lahoud, Oscar Boutros
    Chung, David
    Landau, Heather
    Giralt, Sergio A.
    Usmani, Saad Z.
    Tan, Carlyn Rose
    BLOOD, 2023, 142
  • [2] Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Hamadeh, Issam S.
    Shekarkhand, Tala
    Rueda, Colin
    Firestone, Ross S.
    Wang, Alice X.
    Korde, Neha
    Hultcrantz, Malin L.
    Lesokhin, Alexander M.
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi A.
    Maclachlan, Kylee
    Rajeeve, Sridevi
    Patel, Dhwani
    Shah, Gunjan L.
    Scordo, Michael
    Lahoud, Oscar B.
    Chung, David J.
    Landau, Heather J.
    Giralt, Sergio
    Usmani, Saad Z.
    Tan, Carlyn R.
    BLOOD ADVANCES, 2024, 8 (12) : 3038 - 3044
  • [3] Managing cytokine release syndrome in relapsed/refractory multiple myeloma: experience with teclistamab in the MajesTEC-1 study
    Catamero, Donna
    Benito, Patricia Blazquez
    Shenoy, Samantha
    Chastain, Katherine
    Kruyswijk, Sandy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S315 - S316
  • [4] MANAGING CYTOKINE RELEASE SYNDROME IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXPERIENCE WITH TECLISTAMAB IN THE MAJESTEC-1 STUDY
    Catamero, Donna
    Blazquez, Patricia
    Shenoy, Samantha
    Chastain, Katherine
    Kruyswijk, Sandy
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [5] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [6] Nursing Considerations for Cytokine Release Syndrome in Relapsed/ Refractory Multiple Myeloma: Experience with Teclistamab from the MajesTEC-1 Study
    Catamero, Donna
    Benito, Patricia Blazquez
    Shenoy, Samantha
    Doyle, Margaret
    Fowler, Jessica
    Kobos, Rachel
    Banerjee, Arnob
    Kruyswijk, Sandy
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (03)
  • [7] Cellular Dynamics Following CAR T Cell Therapy Are Associated with Response, Resistance and Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma
    Fischer, Luise
    Born, Patrick
    Weiss, Ronald
    Grieb, Nora
    Seiffert, Sabine
    Boldt, Andreas
    Fricke, Stephan
    Franz, Paul
    Kloetzer, Christina
    Heyn, Simone
    Baber, Ronny
    Wang, Song-Yau
    Bach, Enrica
    Hoffmann, Sandra
    Ussmann, Jule
    Kirchberg, Janine
    Metzeler, Klaus H.
    Herling, Marco
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Sack, Ulrich
    Reiche, Kristin
    Koehl, Ulrike
    Platzbecker, Uwe
    Vucinic, Vladan
    Merz, Maximilian
    BLOOD, 2023, 142
  • [8] Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy
    Charkviani, Mariam
    Vaughan, Lisa E.
    Sandahl, Tyler B.
    Lin, Yi
    Leung, Nelson
    Herrmann, Sandra M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma
    Martin, Thomas G.
    Mateos, Maria Victoria
    Nooka, Ajay
    Banerjee, Arnob
    Kobos, Rachel
    Pei, Lixia
    Qi, Ming
    Verona, Raluca
    Doyle, Margaret
    Smit, Jennifer
    Sun, Weili
    Trancucci, Danielle
    Uhlar, Clarissa
    van de Donk, Niels W. C. J.
    Rodriguez, Cesar
    CANCER, 2023, 129 (13) : 2035 - 2046
  • [10] Correlation of Cytokine Release Syndrome With Prognosis After Chimeric Antigen Receptor T Cell Therapy: Analysis of 54 Patients With Relapsed or Refractory Multiple Myeloma
    Wang, Xue
    Zhao, Lina
    Wang, Jing
    Yao, Yue
    Wang, Jiaojiao
    Ji, Shengwei
    Hua, Tian
    Wang, Shiyuan
    Cheng, Hai
    Shi, Ming
    Li, Zhenyu
    Zeng, Lingyu
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    FRONTIERS IN IMMUNOLOGY, 2022, 13